Has anyone heard of Ly2875358 for metastic uveal melanoma? It is a Lily drug affecting the c-mets. It specifically mentions uveal in one arm..Margaret
Not sure about that one, but Lily just asked Sato for 15 ocular patients to do a Phase one on a C-MEK inhibitor:
Check clinicaltrials.gov for # LY2801653. I might jump on that this spring -- still waiting to see what Ipi/sterotactic did.
LY2875358 (C-MET), looks like it's at about the same developmental stage as the C-MEK trail, so that one may be in the pipeline at Jefferson as well.
Meet and talk to others about melanoma in our forums:
See also: History of the MPIP Forum
–CURE OM Forum
Or, visit the MRF Chat Room!
Subscribe to get updates about melanoma & the MRF’s work in research, education & advocacy.
Helpline: (877) 673-6460
1411 K Street, NW Suite 800
Washington, DC 20005
(800) 673-1290 Office
(202) 347-9678 Fax
The Melanoma Research Foundation (MRF) is leading the melanoma community to transform melanoma from one of the deadliest cancers to one of the most treatable through research, education and advocacy.
The Melanoma Research Foundation is a 501(c)(3) non-profit organization.